De Groot, Anne S.
EpiVax Incorporated,
United States
2025 Rank: 168197
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 715 out of 75944 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 168197 | 130921 |
| Total Cites | 382 | 468 |
| H-index | 7 | 8 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 13 | 13 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 78 | 78 |
| Total Cites to Single+First Authored Papers | 123 | 152 |
| Number of Single+First+Last Authored Papers | 178 | 178 |
| Total Cites to Single+First+Last Authored Papers | 277 | 342 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 287 | 298 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.57 |
| Self-Citation Percentage |
18.38%
|
|
De Groot, Anne S.
EpiVax Incorporated,
United States
2024 Rank: 226497
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 1162 out of 71672 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 226497 | 155899 |
| Total Cites | 303 | 446 |
| H-index | 7 | 9 |
| Hm-index | 2 | 3 |
| Number of Single Authored Papers | 13 | 13 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 78 | 78 |
| Total Cites to Single+First Authored Papers | 101 | 135 |
| Number of Single+First+Last Authored Papers | 173 | 173 |
| Total Cites to Single+First+Last Authored Papers | 214 | 302 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 253 | 270 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.65 |
| Self-Citation Percentage |
32.06%
|
|
De Groot, Anne S.
EpiVax Incorporated,
United States
2023 Rank: 143203
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 811 out of 68279 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 143203 | 141594 |
| Total Cites | 344 | 395 |
| H-index | 8 | 9 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 13 | 13 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 76 | 76 |
| Total Cites to Single+First Authored Papers | 125 | 137 |
| Number of Single+First+Last Authored Papers | 168 | 168 |
| Total Cites to Single+First+Last Authored Papers | 256 | 283 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 263 | 275 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.44 |
| Self-Citation Percentage |
12.91%
|
|
De Groot, Anne S.
EpiVax Incorporated,
United States
2022 Rank: 107667
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 724 out of 65731 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 107667 | 87198 |
| Total Cites | 335 | 472 |
| H-index | 8 | 9 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 11 | 13 |
| Number of Single+First Authored Papers | 75 | 75 |
| Total Cites to Single+First Authored Papers | 123 | 154 |
| Number of Single+First+Last Authored Papers | 160 | 160 |
| Total Cites to Single+First+Last Authored Papers | 226 | 321 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 277 | 303 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.56 |
| Self-Citation Percentage |
29.03%
|
|
De Groot, Anne S.
EpiVax Incorporated,
United States
2021 Rank: 85748
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 514 out of 64670 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 85748 | 65575 |
| Total Cites | 537 | 773 |
| H-index | 10 | 12 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 16 | 17 |
| Number of Single+First Authored Papers | 73 | 73 |
| Total Cites to Single+First Authored Papers | 224 | 277 |
| Number of Single+First+Last Authored Papers | 155 | 155 |
| Total Cites to Single+First+Last Authored Papers | 393 | 564 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 404 | 443 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.74 |
| Self-Citation Percentage |
30.53%
|
|
De Groot, Anne S.
EpiVax Incorporated,
United States
2020 Rank: 91282
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 463 out of 58416 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 91282 | 77420 |
| Total Cites | 381 | 522 |
| H-index | 9 | 10 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 11 | 11 |
| Number of Single+First Authored Papers | 72 | 72 |
| Total Cites to Single+First Authored Papers | 163 | 188 |
| Number of Single+First+Last Authored Papers | 150 | 150 |
| Total Cites to Single+First+Last Authored Papers | 286 | 383 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 275 | 302 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.73 |
| Self-Citation Percentage |
27.01%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.